title: [Is carbamazepine a new etiologic factor in algodystrophy?].
authors.forename: S
authors.initials: S
authors.lastname: Costantino
authors.forename: L
authors.initials: L
authors.lastname: De Galasso
authors.forename: S
authors.initials: S
authors.lastname: Spoto
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids; D003937:Diagnosis, Differential; D004828:Epilepsies, Partial / Q000188:drug therapy; D005260:Female; D000077206:Gabapentin; D006801:Humans; D011247:Pregnancy; D012019:Reflex Sympathetic Dystrophy / Q000139:chemically induced* / Q000175:diagnosis; D012216:Rheumatic Diseases / Q000139:chemically induced*; D012307:Risk Factors; D013577:Syndrome; D013997:Time Factors; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin